European Patent Office

T 1421/05 vom 18.01.2011

Europäischer Rechtsprechungsidentifikator
ECLI:EP:BA:2011:T142105.20110118
Datum der Entscheidung
18. Januar 2011
Aktenzeichen
T 1421/05
Antrag auf Überprüfung von
-
Anmeldenummer
91903945.3
IPC-Klasse
A23L 1/054
Verfahrenssprache
Englisch
Verteilung
An die Kammervorsitzenden und -mitglieder verteilt (B)
Amtsblattfassungen
Keine AB-Links gefunden
Weitere Entscheidungen für diese Akte
-
Zusammenfassungen für diese Entscheidung
-
Bezeichnung der Anmeldung
Docosahexaenoic acid, methods for its production and compounds containing the same
Name des Antragstellers
MARTEK BIOSCIENCES CORPORATION
Name des Einsprechenden
OmegaTech, Inc.
Sanofi-Aventis Deutschland GmbH
Monsanto Company
Nagase Biochemicals, Ltd.
Kammer
3.3.09
Leitsatz

1. Where the business assets in relation to which an opposition was filed have been transferred and at the same time the transferor has contractually agreed to transfer the opposition to the transferee, the status of opponent remains with the transferor in the absence of there being filed with the Office (a) evidence sufficiently evidencing the transfer and (b) a request to recognise the transfer of opponent status (point 3.3).

2. Where in such a case the transferor subsequently ceases to exist but has a universal successor, the status of opponent is capable of passing to that successor (point 4.7).

3. The mere possibility of abuse (in the sense of G 3/97) arising out of such events does not prevent opponent status passing in this way; it is for the proprietor to prove relevant acts of abuse (point 5).

4. An appeal filed by mistake in the name of an opponent who no longer exists but who has a universal successor, and which was obviously intended to be filed on behalf of the person who is the actual opponent and who was prejudiced by the decision, namely the universal successor, is admissible; if necessary the notice of appeal and statement of grounds of appeal may be corrected to record the name of the true appellant/opponent (points 6 and 7).

5. It is not in accordance with normal procedural efficiency and principles of fairness to allow a party to re-open questions relating to the formal allowability of a claim and to attempt to raise a new issue which it had had the opportunity to raise and which it should have raised at an earlier stage of the proceedings, and in doing so to resile from its previous position (point 13.11).

Schlagwörter
Inter-partes transfer of opposition (no)
Transfer of opposition status to universal successor (yes)
Correction of name of appellant (yes)
Admissibility of appeal (yes)
Party entitled to resile from position previously taken in opposition proceedings (no)
Issue decided in first appeal res judicata (yes)
Amendments of party's case in appeal proceedings (no)
Inventive step (yes)
Orientierungssatz
-

ORDER

For these reasons it is decided that:

1. The appeal is accepted as admissible.

2. The name of the Appellant is ordered to be corrected to "Sanofi-Aventis Deutschland GmbH".

3. The appeal is dismissed.